Parvovirus-B19-associated complications in renal transplant recipients

[1]  A. Ekman,et al.  Biological and Immunological Relations among Human Parvovirus B19 Genotypes 1 to 3 , 2007, Journal of Virology.

[2]  U. Querfeld,et al.  Severe parvovirus B19 encephalitis after renal transplantation , 2006, Pediatric transplantation.

[3]  R. Corrocher,et al.  Serologic and molecular detection of human Parvovirus B19 infection. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[4]  T. Larson,et al.  Collapsing and non-collapsing focal segmental glomerulosclerosis in kidney transplants. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  M. Kessler,et al.  Recurrent anemia in kidney transplant recipients with parvovirus B19 infection. , 2006, Transplantation proceedings.

[6]  P. Klenerman,et al.  Tracking of Peptide-Specific CD4+ T-Cell Responses after an Acute Resolving Viral Infection: a Study of Parvovirus B19 , 2006, Journal of Virology.

[7]  Robin Patel,et al.  Parvovirus B19 infection after transplantation: a review of 98 cases. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  K. Brown,et al.  Molecular and Functional Analyses of a Human Parvovirus B19 Infectious Clone Demonstrates Essential Roles for NS1, VP1, and the 11-Kilodalton Protein in Virus Replication and Infectivity , 2006, Journal of Virology.

[9]  A. Ornoy,et al.  Parvovirus B19 in pregnancy. , 2006, Reproductive toxicology.

[10]  K. Brown,et al.  Activation of synoviocytes by the secreted phospholipase A2 motif in the VP1-unique region of parvovirus B19 minor capsid protein. , 2006, The Journal of infectious diseases.

[11]  R. Snanoudj,et al.  Parvovirus B19‐induced anemia in renal transplantation: a role for rHuEPO in resistance to classical treatment , 2006, Transplant International.

[12]  A. Arbini,et al.  A Cluster of Parvovirus B19 Infections in Renal Transplant Recipients: A Prospective Case Series and Review of the Literature , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  M. Çevik,et al.  Glomerulonephritis Associating Parvovirus B19 Infection , 2006, Renal failure.

[14]  P. Klenerman,et al.  Aberrant cellular immune responses in humans infected persistently with parvovirus B19 , 2006, Journal of medical virology.

[15]  S. Doyle,et al.  Establishment of functional B cell memory against parvovirus B19 capsid proteins may be associated with resolution of persistent infection , 2006, Journal of medical virology.

[16]  J. Flynn,et al.  Acute renal failure in a pediatric kidney allograft recipient treated with intravenous immunoglobulin for parvovirus B19 induced pure red cell aplasia , 2005, Pediatric transplantation.

[17]  C. Ki,et al.  Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients , 2005, Clinical transplantation.

[18]  H. Fischer,et al.  Renal anemia aggravated by long-term parvovirus B19 and cytomegalovirus infection in a renal transplant patient: case report and evaluation of B19 seroprevalence in dialysis patients. , 2005, Transplantation proceedings.

[19]  T. Kodera,et al.  Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection. , 2005, Blood.

[20]  P. Klenerman,et al.  Prolonged Activation of Virus-Specific CD8+T Cells after Acute B19 Infection , 2005, PLoS medicine.

[21]  Y. Taguma,et al.  Characteristics of acute glomerulonephritis associated with human parvovirus B19 infection. , 2005, Clinical nephrology.

[22]  P. Klenerman,et al.  Sustained CD8+ T-Cell Responses Induced after Acute Parvovirus B19 Infection in Humans , 2005, Journal of Virology.

[23]  H. Neumayer,et al.  Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real‐time PCR for simultaneous detection of genotypes 1 to 3 , 2005, Journal of medical virology.

[24]  W. Weimar,et al.  Tacrolimus and Pure Red‐Cell Aplasia , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[25]  B. Tatlı,et al.  Central nervous system vasculitis secondary to parvovirus B19 infection in a pediatric renal transplant patient , 2005, Pediatric Nephrology.

[26]  A. Coats,et al.  Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: Negative association between levels of pro‐inflammatory cytokines and development of B19‐associated arthritis , 2004, Journal of medical virology.

[27]  G. Enders,et al.  Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases , 2004, Prenatal diagnosis.

[28]  S. Doyle,et al.  Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. , 2004, Journal of medical microbiology.

[29]  M. Söderlund-Venermo,et al.  Detection and Differentiation of Human Parvovirus Variants by Commercial Quantitative Real-Time PCR Tests , 2004, Journal of Clinical Microbiology.

[30]  W. Irving,et al.  Dual infection with human herpesvirus type 6 and parvovirus B19 in a renal transplant recipient , 1994, Pediatric Nephrology.

[31]  Brown Ke.  Variants of B19 , 2004 .

[32]  A. Srivastava,et al.  α5β1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of β1 integrin for viral entry , 2003 .

[33]  B. Burke,et al.  Cytokine gene polymorphisms associated with symptomatic parvovirus B19 infection , 2003, Journal of clinical pathology.

[34]  D. Lembo,et al.  B19 virus infection in renal transplant recipients. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[35]  H. Asao,et al.  Human Parvovirus B19 Nonstructural Protein (NS1) Induces Cell Cycle Arrest at G1 Phase , 2003, Journal of Virology.

[36]  N. Kiyokawa,et al.  Nephrotic syndrome associated with human parvovirus B19 infection , 2003, Pediatric Nephrology.

[37]  M. Söderlund-Venermo,et al.  A new parvovirus genotype persistent in human skin. , 2002, Virology.

[38]  O. Sezer,et al.  Eradication of parvovirus B19 infection after renal transplantation requires reduction of immunosuppression and high-dose immunoglobulin therapy. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[39]  Quang Tri Nguyen,et al.  Identification and characterization of a second novel human erythrovirus variant, A6. , 2002, Virology.

[40]  S. Laperche,et al.  Genetic Diversity within Human Erythroviruses: Identification of Three Genotypes , 2002, Journal of Virology.

[41]  R. Gohh,et al.  Donor‐transmitted parvovirus infection in a kidney transplant recipient presenting as pancytopenia and allograft dysfunction , 2002, Transplant infectious disease : an official journal of the Transplantation Society.

[42]  M. Mihatsch,et al.  Acute renal failure in a renal allograft recipient treated with intravenous immunoglobulin. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[43]  K. Brown,et al.  Human Parvovirus B19 , 2002, Clinical Microbiology Reviews.

[44]  S. Modrow,et al.  Antibody responses in parvovirus B19 infected patients. , 2002, Pathologie-biologie.

[45]  M. Söderlund-Venermo,et al.  Persistence of human parvovirus B19 in human tissues. , 2002, Pathologie-biologie.

[46]  S. Jordan,et al.  Treatment of Parvovirus B‐19 (PV B‐19) Infection Allows for Successful Kidney Transplantation Without Disease Recurrence , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[47]  Y. Iwafuchi,et al.  Acute endocapillary proliferative glomerulonephritis associated with human parvovirus B19 infection. , 2002, Clinical nephrology.

[48]  S. Choi,et al.  A Case of Persistent Anemia in a Renal Transplant Recipient: Association with Parvovirus B19 Infection , 2002, Scandinavian journal of infectious diseases.

[49]  Y. Mori,et al.  Association of parvovirus B19 infection with acute glomerulonephritis in healthy adults: case report and review of the literature. , 2002, Clinical nephrology.

[50]  H. Tsai,et al.  Fibrosing cholestatic hepatitis possibly related to persistent parvovirus B19 infection in a renal transplant recipient. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[51]  J. Haratake,et al.  Renal Involvement Induced by Human Parvovirus B19 Infection , 2001, Nephron.

[52]  M. Matsumura.  Parvovirus-associated arthritis. , 2001, The American journal of medicine.

[53]  A. Bagga,et al.  Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. , 2001, Kidney international.

[54]  P. Klenerman,et al.  Direct Ex Vivo Measurement of CD8+T-Lymphocyte Responses to Human Parvovirus B19 , 2001, Journal of Virology.

[55]  C. Drachenberg,et al.  Renal involvement of human parvovirus B19 in an immunocompetent host. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[56]  M. Zerbini,et al.  Identification of an immunodominant peptide in the parvovirus B19 VP1 unique region able to elicit a long-lasting immune response in humans. , 2001, Viral immunology.

[57]  E. Kraus,et al.  Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature , 2000, Clinical transplantation.

[58]  J. Levy,et al.  Nephrotoxicity of intravenous immunoglobulin. , 2000, QJM : monthly journal of the Association of Physicians.

[59]  H. Toma,et al.  Discontinuation of immunosuppressive antimetabolite for parvovirus B19-associated anemia in kidney transplant patients. , 2000, Transplantation proceedings.

[60]  A. Komatsuda,et al.  Endocapillary proliferative glomerulonephritis in a patient with parvovirus B19 infection. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[61]  J. Kerr.  Pathogenesis of human parvovirus B19 in rheumatic disease , 2000, Annals of the rheumatic diseases.

[62]  C. Hung,et al.  Parvovirus B19-related acute hepatitis in an immunosuppressed kidney transplant. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[63]  T. Moore.  Parvovirus-associated arthritis , 2000, Current opinion in rheumatology.

[64]  H. Kelly,et al.  The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world , 2000, Epidemiology and Infection.

[65]  F. Zacchello,et al.  Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation. , 2000, Journal of the American Society of Nephrology : JASN.

[66]  D. Middleton,et al.  Parvovirus B19 in kidney transplant patients. , 2000, Transplantation.

[67]  C. Magro,et al.  The cutaneous manifestations of human parvovirus B19 infection. , 2000, Human pathology.

[68]  P. Muretto,et al.  Unusual bone marrow manifestations of parvovirus B19 infection in immunocompromised patients. , 2000, Human pathology.

[69]  P. Li,et al.  Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[70]  A. Tolaymat,et al.  Parvovirus glomerulonephritis in a patient with sickle cell disease , 1999, Pediatric Nephrology.

[71]  B. Charpentier,et al.  Human parvovirus B19 infection in organ transplant recipients , 1999, Clinical transplantation.

[72]  D. Wesson,et al.  Concomitant parvovirus B19 and cytomegalovirus infections after living-related renal transplantation. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[73]  K. Sugamura,et al.  Serologic study of human parvovirus B19 infection in pregnancy in Japan. , 1999, The Journal of infection.

[74]  N. Tanaka,et al.  Human Parvovirus B19 Nonstructural (NS1) Protein Induces Apoptosis in Erythroid Lineage Cells , 1998, Journal of Virology.

[75]  A. Bagga,et al.  Parvovirus B19 infection-related complications in renal transplant recipients: treatment with intravenous immunoglobulin. , 1997, Transplantation.

[76]  T. Rochat,et al.  Parovirus B19-induced red cell aplasia in solid-organ transplant recipients: Two case reports and review of the literature , 1997 .

[77]  M. Salvadori,et al.  Aplastic anemia due to B19 parvovirus infection in cadaveric renal transplant recipients: an underestimated infectious disease in the immunocompromised host. , 1997, Journal of nephrology.

[78]  M. Salvadori,et al.  Unusual incidence of aplastic anaemia due to B-19 parvovirus infection in renal transplant recipients. , 1997, Transplantation proceedings.

[79]  T. Rochat,et al.  Parvovirus [correction of Parovirus] B19-induced red cell aplasia in solid-organ transplant recipients. Two case reports and review of the literature. , 1997, Hematology and cell therapy.

[80]  K. Geissler,et al.  Chronic parvovirus B19 infection-associated pure red cell anaemia in a kidney transplant recipient. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[81]  F. Morinet,et al.  Antibody response to human parvovirus B19 in patients with primary infection by immunoblot assay with recombinant proteins , 1996, Clinical and diagnostic laboratory immunology.

[82]  T. Koerner,et al.  Multiple glycosphingolipids determine the tissue tropism of parvovirus B19. , 1995, The Journal of infectious diseases.

[83]  M. Zerbini,et al.  Parvovirus B19 clearance from peripheral blood after acute infection. , 1995, The Journal of infectious diseases.

[84]  K. Wierenga,et al.  Glomerulonephritis after human parvovirus infection in homozygous sickle-cell disease , 1995, The Lancet.

[85]  Y. Matsunaga,et al.  Human parvovirus B19 infection: Immunohistochemical and electron microscopic studies of skin lesions , 1995, Journal of cutaneous pathology.

[86]  S. Asano,et al.  Pure red cell aplasia caused by parvovirus B19 infection in a renal transplant recipient , 1995, European journal of haematology.

[87]  M. Salvadori,et al.  Severe aplastic anaemia due to B19 parvovirus infection in renal transplant recipient. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[88]  S. Kajigaya,et al.  A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity , 1994, Journal of virology.

[89]  N. Young,et al.  Erythrocyte P antigen: cellular receptor for B19 parvovirus. , 1993, Science.

[90]  M. Anderson,et al.  Human parvovirus infection in homozygous sickle cell disease , 1993, The Lancet.

[91]  S. Kajigaya,et al.  Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface. , 1992, The Journal of clinical investigation.

[92]  S. Asano,et al.  Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation. , 1990, Blood.

[93]  Tadaki Kohtaro,et al.  Enzyme-linked immunosorbent assay for IgG and IgM antibodies against human parvovirus B19: use of monoclonal antibodies and viral antigen propagated in vitro. , 1989 .

[94]  D. W. Jenkins,et al.  Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. , 1989, The New England journal of medicine.

[95]  K. Sugamura,et al.  Enzyme-linked immunosorbent assay for IgG and IgM antibodies against human parvovirus B19: use of monoclonal antibodies and viral antigen propagated in vitro. , 1989, Journal of virological methods.

[96]  B. Cohen,et al.  The prevalence of antibody to human parvovirus B19 in England and Wales. , 1988, Journal of medical microbiology.

[97]  B. Dijkmans,et al.  Human parvovirus B19 DNA in synovial fluid. , 1988, Arthritis and rheumatism.

[98]  N. Young,et al.  Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures , 1987, Journal of virology.

[99]  B. Colvin,et al.  PARVOVIRUS INFECTION AFTER RENAL TRANSPLANT , 1986, The Lancet.

[100]  N. Young,et al.  Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia. , 1986, Blood.

[101]  M. Anderson,et al.  Experimental parvoviral infection in humans. , 1985, The Journal of infectious diseases.